Contract Service Providers Tackle Biopharma Challenges

Pharmaceutical Technology Europe spoke with representatives of contract laboratories and contract development and manufacturing firms about the current state of technology for biopharmaceutical development, analysis, and manufacturing. The panelists include: John Allinson, head of biomarker strategy...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2016-08, p.S18
Format: Article
Language:English
Subjects:
Allinson, John
Antibodies
Automation
Biological products
Biomarkers
Chromatography
Clinical trials
Codamo, Joe
Competition
Consolidation
Contracts
Demand
Economies of scale
Gacheru, Stephen
Gene therapy
Hampson, Brian
Laboratories
Manufacturing
Pharmaceutical sciences
Product development
Product quality
Proteins
Quality control
Reagents
Rook, Martha S
Technology
Testing laboratories
Vectors (Biology)
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pharmaceutical Technology Europe spoke with representatives of contract laboratories and contract development and manufacturing firms about the current state of technology for biopharmaceutical development, analysis, and manufacturing. The panelists include: John Allinson, head of biomarker strategy, drug development services at LGC; Martha S. Rook, head of novel therapies, process solutions, Merck; Joe Codamo, general manager, Patheon; Brian Hampson, vice-president.
ISSN:1753-7967